Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet factor 4 activity and thromboembolic episodes

T Okuno, D Crockatt

    American Journal of Clinical Pathology
    |April 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Complete nucleotide sequence of spring beauty latent virus, a bromovirus infectious to Arabidopsis thaliana.

    Archives of virology·2003
    Same author

    Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.

    Journal of human virology·2002
    Same author

    Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts.

    Scandinavian journal of gastroenterology·2002
    Same author

    Low-dose ACTH therapy for West syndrome: initial effects and long-term outcome.

    Neurology·2002
    Same author

    [Efficacy of a single-day administration of levofloxacin for the prevention of urinary tract infections after urogenital examinations and treatments for outpatients].

    Hinyokika kiyo. Acta urologica Japonica·2002
    Same author

    [Seizure and developmental prognosis of West syndrome--combination therapy with high-dose vitamin B6, valproate and low-dose ACTH].

    No to hattatsu = Brain and development·2001

    Elevated platelet factor 4 (PF4) levels indicate high platelet turnover, common in conditions like myocardial infarction and thromboembolism. Measuring PF4 activity may aid in diagnosing thromboembolic disorders.

    Area of Science:

    • Hematology
    • Clinical Chemistry

    Background:

    • Platelet factor 4 (PF4) is a chemokine released from activated platelets.
    • Its role in various disease states, particularly those involving platelet activation and turnover, warrants investigation.

    Purpose of the Study:

    • To evaluate platelet factor 4 (PF4) activity in a cohort of patients with diverse medical conditions.
    • To explore the association between elevated PF4 levels and specific diseases, including thromboembolic events.

    Main Methods:

    • Platelet factor 4 (PF4) activity was measured in 323 patients.
    • Patient data included diagnoses such as myocardial infarction, thromboembolism, hepatic diseases, and prosthetic heart valves.

    Main Results:

    • Elevated PF4 levels (≥30%) were observed in patients with recent myocardial infarctions, recent thromboembolism, hepatic diseases, and thrombocytopenia.

    Related Experiment Videos

  • Three out of four patients with prosthetic heart valves exhibited markedly elevated PF4 activity.
  • High PF4 activity correlated with conditions characterized by high platelet turnover, such as intravascular coagulation and thromboembolism.

    • Conclusions:

    • Elevated platelet factor 4 (PF4) activity is associated with increased platelet turnover.
    • PF4 activity measurement may serve as a valuable diagnostic marker for thromboembolism.